Cargando…
Designing circulating tumor DNA-based interventional clinical trials in oncology
Circulating tumor (ct) DNA is a powerful tool that can be used to track cancer beyond a single snapshot in space and time. It has potential applications in detecting minimal residual disease and predicting relapse, in selecting patients for tailored treatments, and in revealing mechanisms of respons...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474042/ https://www.ncbi.nlm.nih.gov/pubmed/31003596 http://dx.doi.org/10.1186/s13073-019-0634-x |